Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New forms of hormonal contraception].

U Gaspard1, C Buicu, F van den Brûle

  • 1Service de Gynécologie, CHU Sart Tilman B 35, Université de Liège, 4000 Liège 1, Belgique.

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|May 11, 2000
PubMed
Summary

New hormonal contraceptives offer high effectiveness with low doses for improved safety and tolerance. These options enhance individualized birth control therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low thrombin generation in postmenopausal women using estetrol.

Climacteric : the journal of the International Menopause Society·2024
Same author

Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women.

Climacteric : the journal of the International Menopause Society·2022
Same author

[«I am not pregnant !» About denial of pregnancy…].

Revue medicale de Liege·2020
Same author

Exploring the interest in and the usage of the internet among patients eligible for osteoporosis screening.

Calcified tissue international·2015
Same author

[The use of intrauterine device in nulliparous over 18 years: a Belgian consensus].

Journal de pharmacie de Belgique·2015
Same author

[Zoely, a combined oral contraceptive, monophasic pill containing estradiol and nomegestrol acetate].

Revue medicale de Liege·2012

Area of Science:

  • Reproductive Health
  • Endocrinology
  • Pharmacology

Context:

  • Advancements in hormonal contraception are crucial for meeting diverse patient needs.
  • Existing methods may have limitations in terms of side effects or efficacy.

Purpose:

  • To review novel hormonal contraceptive formulations.
  • To highlight their effectiveness, safety, and tolerability profiles.

Summary:

  • Discusses a low-dose ethinylestradiol/gestodene combination for 24-day use.
  • Details a progestogen-only etonogestrel subcutaneous implant.
  • Describes a levonorgestrel-releasing intrauterine system.

Impact:

  • These new contraceptives offer enhanced options for personalized birth control.
  • Improved safety and tolerance profiles can increase user adherence and satisfaction.

Related Experiment Videos